Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23:6113–6119. https://doi.org/10.1158/1078-0432.CCR-16-3227

Article  CAS  PubMed  Google Scholar 

Deng M, Chen HH, Zhu X, Luo M, Zhang K, Xu CJ et al (2019) Prevalence and clinical outcomes of germline mutations in and genes in 2769 unselected breast cancer patients in China. Int J Cancer 145:1517–1528. https://doi.org/10.1002/ijc.32184

Article  CAS  PubMed  Google Scholar 

Su LM, Xu Y, Ouyang T, Li JF, Wang TF, Fan ZQ et al (2020) Contralateral breast cancer risk in and mutation carriers in a large cohort of unselected Chinese breast cancer patients. Int J Cancer 146:3335–3342. https://doi.org/10.1002/ijc.32918

Article  CAS  PubMed  Google Scholar 

Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402–2416. https://doi.org/10.1001/jama.2017.7112

Article  CAS  PubMed  Google Scholar 

Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J et al (2016) Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat 156:441–445. https://doi.org/10.1007/s10549-016-3766-3

Article  CAS  PubMed  Google Scholar 

Su L, Xu Y, Ouyang T, Li J, Wang T, Fan Z et al (2020) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients. Int J Cancer 146:3335–3342. https://doi.org/10.1002/ijc.32918

Article  CAS  PubMed  Google Scholar 

Mcguigan A, Whitworth J, Andreou A, Hearn T, Tischkowitz M et al (2022) Multilocus inherited neoplasia allele syndrome (MINAS): an update. Eur J Hum Genet 30:265–270. https://doi.org/10.1038/s41431-021-01013-6

Article  PubMed  PubMed Central  Google Scholar 

Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O et al (2011) Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol 22:964–966. https://doi.org/10.1093/annonc/mdq460

Article  CAS  PubMed  Google Scholar 

Heidemann S, Fischer C, Engel C, Fischer B, Harder L, Schlegelberger B et al (2012) Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat 134:1229–1239. https://doi.org/10.1007/s10549-012-2050-4

Article  CAS  PubMed  Google Scholar 

Noh JM, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW et al (2012) Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. Breast Cancer Res Treat 131:217–222. https://doi.org/10.1007/s10549-011-1718-5

Article  CAS  PubMed  Google Scholar 

Bang YJ, Kwon WK, Nam SJ, Kim SW, Chae BJ, Lee SK et al (2022) Clinicopathological characterization of double heterozygosity for BRCA1 and BRCA2 variants in Korean breast cancer patients. Cancer Res Treat 54:827–833. https://doi.org/10.4143/crt.2021.791

Article  CAS  PubMed  Google Scholar 

Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A et al (2005) Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42:e20. https://doi.org/10.1136/jmg.2004.027243

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL et al (2016) Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res 18:112. https://doi.org/10.1186/s13058-016-0768-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638–1645. https://doi.org/10.1200/JCO.2004.04.179

Article  CAS  PubMed  Google Scholar 

Kitahara M, Hozumi Y, Machinaga M, Hayashi Y (2021) A case of triple-negative breast cancer with germline pathogenic variants in both BRCA1 and BRCA2. Case Rep Oncol 14:1645–1651. https://doi.org/10.1159/000520148

Article  PubMed  PubMed Central  Google Scholar 

Nomizu T, Matsuzaki M, Katagata N, Kobayashi Y, Sakuma T, Monma T et al (2015) A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. Breast Cancer 22:557–561. https://doi.org/10.1007/s12282-012-0432-4

Article  PubMed  Google Scholar 

Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J et al (2016) Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat 158:455–462. https://doi.org/10.1007/s10549-016-3902-0

Article  CAS  PubMed  Google Scholar 

Su L, Zhang J, Meng H, Ouyang T, Li J, Wang T et al (2018) Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer. Clin Genet 94:165-169. https://doi.org/10.1111/cge.13256

Wang C, Zhang J, Wang Y, Ouyang T, Li J, Wang T et al (2015) Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Ann Oncol 26:523–528. https://doi.org/10.1093/annonc/mdu559

Article  CAS  PubMed  Google Scholar 

Meng H, Yao L, Yuan H, Xu Y, Ouyang T, Li J et al (2020) BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients. Int J Cancer 146:3044–3052. https://doi.org/10.1002/ijc.32877

Article  CAS  PubMed  Google Scholar 

Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490. https://doi.org/10.1200/JCO.2002.20.6.1480

Article  CAS  PubMed  Google Scholar 

Zuradelli M, Peissel B, Manoukian S, Zaffaroni D, Barile M, Pensotti V et al (2010) Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics. Breast Cancer Res Treat 124:251–258. https://doi.org/10.1007/s10549-010-0853-8

Article  CAS  PubMed  Google Scholar 

Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y et al (2022) Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol 8:871–878. https://doi.org/10.1001/jamaoncol.2022.0476

Article  PubMed  PubMed Central  Google Scholar 

Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY et al (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319:2401–2409. https://doi.org/10.1001/jama.2018.6228

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang ZM, Wilson CL, Armstrong GT, Hudson MM, Zhang JH, Nichols KE et al (2019) Association of germline BRCA2 mutations With the risk of pediatric or adolescent non-hodgkin lymphoma. JAMA Oncol 5:1362–1364. https://doi.org/10.1001/jamaoncol.2019.2203

Article  PubMed  PubMed Central  Google Scholar 

Usui Y, Iwasaki Y, Matsuo K, Endo M, Kamatani Y, Hirata M et al (2022) Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer Sci 113:3972–3979. https://doi.org/10.1111/cas.15522

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R et al (2018) Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68:959–969. https://doi.org/10.1016/j.jhep.2018.01.009

Article  CAS  PubMed  Google Scholar 

Maynard H, Stadler ZK, Berger MF, Solit DB, Ly M, Lowery MA et al (2020) Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings. Cancer 126:1995–2002.